#MDA2021 – Long-term Use of AMX0035 of Aid in Rapidly Advancing Disease
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 MDA Virtual Clinical and Scientific Conference,…
Articles by Marta Figueiredo, PhD
#MDA2021 – Occurrence of Bulbar Onset ALS Higher in the Midwest
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 MDA Virtual Clinical and Scientific Conference,…
#MDA2021 – Respiratory Difficulties Can Greatly Affect Patients’ Daily Independence
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 MDA Virtual Clinical and Scientific Conference,…
Amylyx Planning to Ask Health Canada to Approve AMX0035 to Treat ALS
Amylyx Pharmaceuticals plans to soon apply to Health Canada, requesting approval of oral AMX0035 to treat amyotrophic lateral sclerosis…
Eurordis Survey: Healthcare Experience Worse for Rare Disease Patients
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
ALS Association Emphasizes Importance of Feeding Tubes
To commemorate Feeding Tube Awareness Week, the ALS Association recently highlighted the benefits of feeding tubes in the lives of…
Patients, Caregivers in UK to Help Design Tool for Feeding Tube Decisions
People with amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MNDs), as well as their caregivers and healthcare…
COVID-19 Safety Measures Announced for Biomarker Study
Mitsubishi Tanabe Pharma America (MTPA) is taking proactive measures to address patient safety in its REFINE-ALS biomarker study during…
NurOwn May Be Given to Early ALS Patients in US Who Finished Phase 3 Trial
BrainStorm Cell Therapeutics has opened an expanded access program (EAP) in the U.S. to allow certain amyotrophic lateral…
Two ALS Staging Systems May Be Useful Assessment Tools in Clinical Trials
Two amyotrophic lateral sclerosis (ALS) staging systems — the King’s and the Milano-Torino’s, known as MiToS — may…